SYNERGISTIC COMBINATIONS OF RETINOID RECEPTOR LIGANDS AND SELECTED CYTOTOXIC AGENTS FOR TREATMENT OF CANCER

摘要

Chemotherapeutic combinations of selected cytotoxic agents and RAR alpha/beta selective agonists (see Figure 1) or RAR pan antagonists (see Figure 2) for use in treating cancer and lowering the effective cytotoxic dose of the selected cytotoxic agent are provided.